Vontobel Holding
IBB icon

Vontobel Holding’s iShares Biotechnology ETF IBB Stock Holding History

Vontobel Holding’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Sell
2,074
-75
-3% -$12.9K ﹤0.01% 1137
2026
Q1 		$363K Sell
2,149
-933
-30% -$160K ﹤0.01% 945
2025
Q4 		$520K Sell
3,082
-1,475
-32% -$240K ﹤0.01% 979
2025
Q3 		$658K Sell
4,557
-907
-17% -$124K ﹤0.01% 855
2025
Q2 		$691K Buy
5,464
+341
+7% +$41.9K ﹤0.01% 804
2025
Q1 		$655K Buy
5,123
+2,164
+73% +$293K ﹤0.01% 705
2024
Q4 		$391K Buy
2,959
+497
+20% +$69.9K ﹤0.01% 849
2024
Q3 		$358K Buy
2,462
+27
+1% +$3.91K ﹤0.01% 874
2024
Q2 		$334K Sell
2,435
-81
-3% -$10.8K ﹤0.01% 869
2024
Q1 		$345K Sell
2,516
-1,900
-43% -$259K ﹤0.01% 870
2023
Q4 		$600K Sell
4,416
-81
-2% -$9.88K 0.01% 749
2023
Q3 		$550K Sell
4,497
-2,877
-39% -$366K 0.01% 738
2023
Q2 		$936K Buy
7,374
+2,151
+41% +$279K 0.01% 615
2023
Q1 		$675K Sell
5,223
-2,588
-33% -$339K 0.01% 704
2022
Q4 		$1.03M Buy
7,811
+3,526
+82% +$456K 0.01% 575
2022
Q3 		$501K Sell
4,285
-1,441
-25% -$179K 0.01% 713
2022
Q2 		$674K Buy
5,726
+666
+13% +$79.1K 0.01% 637
2022
Q1 		$659K Buy
5,060
+440
+10% +$57.3K 0.01% 719
2021
Q4 		$705K Buy
4,620
+328
+8% +$50.8K 0.01% 722
2021
Q3 		$694K Sell
4,292
-9,467
-69% -$1.59M 0.01% 702
2021
Q2 		$2.25M Buy
13,759
+3,964
+40% +$611K 0.02% 411
2021
Q1 		$1.48M Buy
9,795
+7,395
+308% +$1.17M 0.01% 459
2020
Q4 		$364K Buy
+2,400
New +$343K ﹤0.01% 749

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Vontobel Holding's IBB Position: Q2 2026 in Review

Vontobel Holding reduced its iShares Biotechnology ETF (IBB) stake by 3.5% in Q2 2026, selling an estimated $12.9K and leaving 2,074 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Vontobel Holding first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.25M in Q2 2021. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Vontobel Holding held 2,074 shares of iShares Biotechnology ETF worth $394K as of Q2 2026.
  • Vontobel Holding sold 75 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.9K.
  • iShares Biotechnology ETF made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1137 holding.
  • Vontobel Holding first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's iShares Biotechnology ETF position peaked at $2.25M in Q2 2021.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.